Target Blood Pressure: ≤ 140/90 (Answer C)
For this 62-year-old man with acute intracerebral hemorrhage (ICH), the target systolic blood pressure should be approximately 140 mm Hg, maintained within a range of 130-150 mm Hg. This corresponds most closely to answer C (≤ 140/90).
Rationale Based on Current Guidelines
The 2022 AHA/ASA guidelines provide clear direction for blood pressure management in acute ICH 1. For patients with mild to moderate ICH presenting with SBP between 150-220 mm Hg, acute lowering of SBP to a target of 140 mm Hg with the goal of maintaining in the range of 130-150 mm Hg is safe and may be reasonable for improving functional outcomes 1.
Critical Thresholds to Remember
- Upper limit: The patient's SBP is likely >150 mm Hg (given uncontrolled hypertension), so reduction is indicated
- Target: 140 mm Hg
- Maintenance range: 130-150 mm Hg
- Danger zone: Avoid dropping SBP below 130 mm Hg - this is potentially harmful and associated with worse outcomes 1
Timing and Implementation
Treatment should be initiated within 2 hours of ICH onset and the target should be reached within 1 hour to reduce hematoma expansion and improve functional outcomes 1. This aggressive timeline is supported by subgroup analysis showing that earlier BP reduction (within 2 hours) is associated with lower risk of hematoma expansion 1.
Key Implementation Points
- Use smooth, sustained BP control avoiding large fluctuations - SBP variability is independently associated with death and severe disability 1
- Choose IV agents with rapid onset and short duration for easy titration (nicardipine was used in ATACH-2 trial)
- Avoid venous vasodilators due to potential effects on intracranial pressure 1
Critical Pitfalls to Avoid
Overly aggressive BP lowering is harmful. Recent real-world data demonstrates that:
- Relative SBP reduction >20% in the first 48 hours is associated with renal adverse events (OR 8.99), brain ischemia (OR 22.5), and worse functional outcomes (OR 11.79 for mRS 4-6) 2
- Hypotension episodes requiring vasopressor support increase the risk of secondary organ injury 2
- In clinical practice, patients often spend >50% of time with SBP <140 mm Hg, predisposing them to complications 2
Why Other Answers Are Incorrect
- Answer A (≤ 220/120): Too permissive - elevated BP is associated with hematoma expansion, neurological deterioration, and mortality 1
- Answer B (≤ 185/110): This target is used for ischemic stroke patients receiving thrombolysis, not for hemorrhagic stroke
- Answer D (≤ 180/105): Represents the older "standard treatment" arm from ATACH-2 trial; current evidence supports more intensive reduction to 140 mm Hg 1
Special Considerations
If this patient has large or severe ICH or requires surgical decompression, the safety and efficacy of intensive BP lowering are not well established 1. However, the case describes a patient who appears to have mild-moderate severity (able to present with headache and altered mentation rather than coma), making the 140 mm Hg target appropriate.
The evidence base comes primarily from INTERACT2 and ATACH-2 trials, with meta-analyses consistently supporting a target around 140 mm Hg as the optimal balance between preventing hematoma expansion and avoiding hypoperfusion-related complications 1, 3, 4.